000			01916 a2200517 4500
005			20250515224302.0
264		0	_c20100727
008			201007s 0 0 eng d
022			_a1468-2060
024	7		_a10.1136/ard.2009.121160 _2doi
040			_aNLM _beng _cNLM
100	1		_aVisser, K
245	0	0	_aA matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. _h[electronic resource]
260			_bAnnals of the rheumatic diseases _cJul 2010
300			_a1333-7 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aArthritis, Rheumatoid _xdiagnostic imaging
650	0	4	_aAutoantibodies _xblood
650	0	4	_aC-Reactive Protein _xmetabolism
650	0	4	_aDisease Progression
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEpidemiologic Methods
650	0	4	_aFemale
650	0	4	_aGlucocorticoids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aPeptides, Cyclic _ximmunology
650	0	4	_aPrednisone _xtherapeutic use
650	0	4	_aRadiography
650	0	4	_aRheumatoid Factor _xblood
700	1		_aGoekoop-Ruiterman, Y P M
700	1		_ade Vries-Bouwstra, J K
700	1		_aRonday, H K
700	1		_aSeys, P E H
700	1		_aKerstens, P J S M
700	1		_aHuizinga, T W J
700	1		_aDijkmans, B A C
700	1		_aAllaart, C F
773	0		_tAnnals of the rheumatic diseases _gvol. 69 _gno. 7 _gp. 1333-7
856	4	0	_uhttps://doi.org/10.1136/ard.2009.121160 _zAvailable from publisher's website
999			_c19851082 _d19851082